Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 7 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 7 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Drug Evaluation

Article
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
Ruth Van Daele, Isabel Spriet & Johan Maertens
Pages: 539-550
Published online: 01 Jun 2020
AbstractforPosaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation | Full Text | References | PDF (1.2 MB) | EPUB
  • 689 Views
  • 11 CrossRef citations
  • 0Altmetric

Review

Pharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection
Piyanuch Wonganan, Wacharee Limpanasithikul, Suree Jianmongkol, Stephen J. Kerr & Kiat Ruxrungtham
Pages: 551-564
Published online: 07 Jun 2020
AbstractforPharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection | Full Text | References | PDF (2.3 MB) | EPUB
  • 610 Views
  • 7 CrossRef citations
  • 0Altmetric
Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals
Lauren R. Cirrincione, Tessa Senneker, Kimberly K. Scarsi & Alice Tseng
Pages: 565-581
Published online: 27 Jun 2020
AbstractforDrug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals | Full Text | References | PDF (704.5 KB) | EPUB
  • 1012 Views
  • 10 CrossRef citations
  • 0Altmetric
An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome
Taraneh Mousavi, Shekoufeh Nikfar & Mohammad Abdollahi
Pages: 583-604
Published online: 18 Jun 2020
AbstractforAn update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome | Full Text | References | PDF (1.8 MB) | EPUB
  • 693 Views
  • 11 CrossRef citations
  • 0Altmetric
Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population
Briana L. Scott, Chi D. Hornik & Kanecia Zimmerman
Pages: 605-616
Published online: 07 Jun 2020
AbstractforPharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population | Full Text | References | PDF (443.1 KB) | EPUB
  • 685 Views
  • 5 CrossRef citations
  • 0Altmetric
Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients
Bartosz Szostak, Filip Machaj, Jakub Rosik & Andrzej Pawlik
Pages: 617-626
Published online: 19 Jun 2020
AbstractforUsing pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients | Full Text | References | PDF (428.9 KB) | EPUB
  • 612 Views
  • 14 CrossRef citations
  • 0Altmetric
ADME and toxicity considerations for tramadol: from basic research to clinical implications
Mohsen Doostmohammadi & Hamid-Reza Rahimi
Pages: 627-640
Published online: 27 Jun 2020
AbstractforADME and toxicity considerations for tramadol: from basic research to clinical implications | Full Text | References | PDF (841.8 KB) | EPUB
  • 517 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Research

Article
Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure
Megan K Young, Shu-Kay Ng, Graeme R Nimmo & Allan W Cripps
Pages: 641-644
Published online: 03 May 2020
AbstractforPharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure | Full Text | References | PDF (408.4 KB) | EPUB
  • 96 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Genetic polymorphisms of drug-metabolizing enzymes in older and Newer Anti-Seizure Medications
Gianluca D’Onofrio et al.
Editorial | Published online: 29 May 2024
Free Access
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles